Seventh Sense Biosystems is improving the quality, convenience and cost-effectiveness of medical care through painless, simplified and safe blood collection. The company's proprietary Touch Activated Phlebotomy™ (TAP) technology platform is being developed to eliminate the discomfort, inconvenience, and expert intervention associated with traditional blood sampling. Drawn through a painless, one-step process by almost anyone, anywhere, anytime, blood samples collected with TAP can be utilized across a broad spectrum of diagnostic applications. TAP's universal, scalable design holds the potential to not only expand the reach and effectiveness of blood collection to hard-to-sample populations and difficult settings, but also to improve the safety and ease of collection for all patients, thereby enhancing care and enabling better diagnostics.
